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Abstract
Background: International studies report that nurse clinics improve healing rates for the leg ulcer
population. However, these studies did not necessarily deliver similar standards of care based on evidence
in the treatment venues (home and clinic). A rigorous evaluation of home versus clinic care is required to
determine healing rates with equivalent care and establish the acceptability of clinic-delivered care.
Methods: Health Services RCT was conducted where mobile individuals were allocated to either home
or nurse clinic for leg ulcer management. In both arms, care was delivered by specially trained nurses,
following an evidence protocol. Primary outcome: 3-month healing rates. Secondary outcomes: durability
of healing (recurrence), time free of ulcers, HRQL, satisfaction, resource use. Data were collected at base-
line, every 3 months until healing occurred, with 1 year follow-up. Analysis was by intention to treat.
Results: 126 participants, 65 randomized to receive care in their homes, 61 to nurse-run clinics. No
differences found between groups at baseline on socio-demographic, HRQL or clinical characteristics.
mean age 69 years, 68% females, 84% English-speaking, half with previous episode of ulceration, 60% ulcers
at inclusion < 5 cm2 for < 6 months. No differences in 3-month healing rates: clinic 58.3% compared to
home care at 56.7% (p = 0.5) or in secondary outcomes.
Conclusion: Our findings indicate that organization of care not the setting where care is delivered
influences healing rates. Key factors are a system that supports delivery of evidence-based
recommendations with care being provided by a trained nursing team resulting in equivalent healing rates,
HRQL whether care is delivered in the home or in a community nurse-led clinic.
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Background
Chronic wounds are not typically seen as a pressing health
care problem, yet leg ulcers comprise a common, com-
plex, and costly condition. International studies demon-
strate that leg ulcer occurrence increases with age [1-5];
chronic leg ulcers are a significant burden to both patients
and the health care system [6-10]. Patients tend to receive
poorly integrated services in multiple settings. Delivery of
leg ulcer care through integrated, nurse-led community
clinics has been enthusiastically endorsed in the UK since
the early 1990s [11-17]. It was postulated that not only
would clinic-based care provide social support, encourage
mobility, and improve patient outcomes through
improved linkages and greater consistency of treatment
between specialist and district home care, it would also
reduce the number of providers and specialties involved.
In the influential London Riverside project, five home
nursing districts, one tertiary setting, and the Charing
Cross Hospital were consolidated in a health services
arrangement for clinic care provision [13,18]. A pre-post
audit at 12 weeks revealed that leg ulcer healing rates
improved from 22% to 69% with the new service. Subse-
quently two controlled studies [14,16], one of which was
randomized [14,16], were unable to achieve such notable
improvements as the Riverside project (24% to 34%, p =
ns [14] and from 26% to 42%, p = 0.001 [16]).
Many countries are shifting to nurse delivered community
care for the leg ulcer population despite a lack of compar-
ison to equivalent home care.[19] On the surface, this is
an appealing trend particularly from a resource perspec-
tive. Use of community clinics transfers the time and
expense of travel to individuals from home care agencies,
where the nurse travels to individuals' homes. Closer
examination of these studies, however, indicates an ineq-
uity between clinic and home care groups; the implemen-
tation of nurse clinics are typically characterized by more
skilled provider teams and closer adherence to evidence-
based recommendations than the comparator groups
which often neglected to include compression therapy. If
the quality of provider teams, assessment, and manage-
ment were held constant, would there still be improve-
ment with care delivered in clinics?
Canada's unique challenges necessitated comparisons of
clinic-based, community nursing care to home care mod-
els. Factors such as the weather extremes, distance to
health services, variant urban-rural mix in many commu-
nities, and the limited experience with nurse-run clinics
have to be considered. As well, the regional and individual
acceptance of such a service delivery model is unknown.
To respond to this, we first undertook research to evaluate
the impact of evidence-based leg ulcer care delivered with
the usual model (home visiting) and clinics using a spe-
cially trained nursing team. In a one year pre-post evalua-
tion we demonstrated improvements in 3-month healing
rates from 23% to 56%, similar to rates achieved in the UK
studies. Median supply costs declined from $1923 to
$406 (Canadian dollars) and nursing visits reduced from
37 to 25 visits per case [20]. In the post-implementation
phase, we nested a randomized controlled trial into the
design to determine the relative effectiveness and effi-
ciency of clinic-delivered versus home-delivered care with
individuals who were mobile. Both the control (home
care) and experimental (clinic) arms were treated by the
same team of specially trained nurses, and both followed
the same evidence-based protocol for care including com-
pression bandaging [21]. The intent of the trial, within
our larger effort of implementing evidence-based wound
care, was to rigorously evaluate the setting of care in order
to inform reorganization efforts as to whether community
home care, clinics, or both could be options for Canadian
home care authorities. The resource utilization informa-
tion, albeit limited to data available from administrative
sources is intended to provide foundational information
for further study. This paper reports the results of that ran-
domized trial of the effectiveness and efficiency of home
versus clinic delivered care for individuals with leg ulcers.
Methods
Design
We conducted a prospective, randomized two-arm trial to
evaluate the effectiveness and efficiency of community leg
ulcer clinics (intervention) with care delivered through
home visiting (usual care) by comparing individual and
system level outcomes, including a one year post-healing
follow-up. We hypothesized that receiving care in the
clinic setting would improve healing rates at 3 months
(primary outcome).
Setting and sample
From a large urban-rural region in Ontario overseen by
two Community Care Access Centres (home care authori-
ties) and two home nurse agencies, the study population
was comprised of those eligible for community leg ulcer
care, including those already in care and any new referrals
who met four inclusion criteria:
1. Admission to home care for care of a leg ulcer (an ulcer
below the knee to the foot)
2. Having leg ulcer of venous or mixed venous and arterial
etiology and eligible for compression bandaging.
3. Ability to travel to clinic (i.e. individuals able to travel
outside their home)BMC Health Services Research 2008, 8:243 http://www.biomedcentral.com/1472-6963/8/243
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4. No major contraindication for clinic care (i.e. domestic
issues that would decrease compliance for clinic visits e.g.
not being able to leave an ill spouse)
Procedures
Upon referral to the regional home care service for leg
ulcer care, individuals received a comprehensive, stand-
ardized clinical assessment by specially trained registered
nurses. Mobile individuals, i.e. either independently
mobile or requiring minimal assistance, were informed of
the study and invited to participate. Consenting individu-
als were then randomly allocated to receive leg ulcer care
in either a nurse-run clinic or in their own home. A com-
puter-generated schedule of randomization was used to
allocate participants to community clinic or home care.
Allocation was sealed in opaque, serially numbered enve-
lopes and to eliminate any possibility of bias, randomiza-
tion was controlled centrally from the university research
office and stratified by client status (existing client or new
referral).
The same nursing team delivered care in both the home
and clinic settings. Care for leg ulcer management was
standardized and guided by international evidence-based
recommendations [12,21]. The leg ulcer care manage-
ment protocol was developed using the Practice Guideline
Evaluation and Adaptation Cycle (PGEAC) which is a
process for evaluating and adapting existing practice
guideline recommendations for local use [21-23]. The
process involved bringing together an interdisciplinary
task force comprised of clinical leaders representing home
nursing, enterostomal therapy, family practice, vascular
surgery, dermatology, and haematology to systematically
identify and review existing leg ulcer guidelines. The task
force appraised the quality of the existing recommenda-
tions using the Guidelines Appraisal Instrument [24,25],
their content, clinical utility, and feasibility of implement-
ing the recommendations in the local context and pro-
duced a local care protocol adapted from the guidelines
reviewed [22]. We sent the draft protocol to home care
nurses and family physicians for review and feedback
[26,27]. It was kept current through scheduled reviews by
the task force [28]. Agency nurses involved in the study
received additional training and were familiar with the
evidence for practice supporting the guideline recommen-
dations.
Ethics, consent and random assignment to setting of care
Home care decision-makers weighed the potential risks
and benefits of randomly assigning clients to setting of
care and concluded that the potential benefits outweighed
the risks because: 1) the duration of the study was limited,
2) flexibility was built into the study design to permit cli-
nicians to exclude clients from clinic care if clinical or
social circumstances warranted it and these would be
tracked, and 3) the need for robust findings was essential
to determine the value of providing leg ulcer clinic care in
Canada.
Prior to their first visit, all clients meeting the criteria for
clinic care were provided with a written explanation about
the need and rationale for the study. At the time of intake
assessment, an attending nurse verbally explained the trial
and sought written informed consent. Assistance with
transportation to the clinic was available in the form of
taxi chits or bus tickets if required. Ethics approval was
received from the Ottawa Health Research Institute Ethics
Board.
Data collection and management
Baseline data collection began at the time of initial assess-
ment through interview, clinical assessment and chart
review. Socio-demographic and clinical assessment, and
measurements of primary and secondary outcomes were
collected at baseline. Measurement of ulcer size was
repeated at 3-month intervals until complete healing, or
until 12 months post study entry, whichever came first. If
healing occurred between these intervals measurements
were taken at that time.
Quality assurance procedures ensured the integrity of the
trial [29-31]. Aspects of data management were elabo-
rated in a detailed protocol manual for the study team. A
log record was maintained to track the status of partici-
pants throughout the duration of the trial. Once recruited,
participants were assigned a code number used on all sub-
sequent documentation to ensure confidentiality. With-
drawals from either arm of the study were monitored and
reasons documented. Data were analyzed using SPSS (ver-
sion 12) software. Case records (10%) were randomly
selected to assess data entry accuracy every 3 months.
Outcome measurement
The primary outcome for the trial was healing at 3
months. Other healing outcomes were reduction in size
and sustainability of healing. These measures were chosen
based on clinical feasibility and to allow comparisons to
other leg ulcer studies in the literature. 'Healed' was
defined as re-epithelialisation of all ulcers [14]. The 3
month timeframe to healing continues to be used in many
studies [32] and is encouraged by international practice
guidelines as it serves as a useful quality outcome [33,34].
Ulcer size was assessed by calculating ulcer area (cm2).
The line of epithelium was traced on acetate with an indel-
ible pen and the ulcer area calculated using computer
planimetry. This method to serially measure ulcer size has
been shown to be reliable and valid [33,35-37]. As with
our previous studies, attending nurses are alerted to report
to the trial office (phone number is on chart) when an
ulcer has healed so that the date of healing can be notedBMC Health Services Research 2008, 8:243 http://www.biomedcentral.com/1472-6963/8/243
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in the tracking database. This is typically the point when
individuals come off of service and if there was any con-
cerns a further visit was set-up with the clinical leader of
the service. It was not possible to conduct blinded out-
come assessment at the point of care given the provider
would already know which setting care was being
received. Additional independent, blinded visits at a sep-
arate location, given the dispersal of individuals in the
community would have been prohibitive. Sustainability
of healing was assessed by the time to first recurrence after
the ulcer healed, and time free of ulcers during the 12-
month follow-up from admission.
Pain and health related quality of life were assessed using
the McGill Short Form Pain Questionnaire (SF-MPQ) [38-
40], and the Medial Outcomes Study Short-Form Health
Survey [41,42]. The SF-MPQ is designed to assess the
multi-dimensional nature of the pain experience and has
been demonstrated to be a reliable, valid and consistent
measure, and it has been used in studies of patients with
leg ulcers [14,43,44]. The Short Form Health Survey meas-
ures self-reported aspects of HRQOL, including physical
function, role physical, bodily pain, general health, vital-
ity, social function, role emotional and mental health.
Two component scores, the Physical and Mental Compo-
nent Summaries, are standardized to a mean of 50, with a
score above 50 representing better than average function
and below 50 poorer than average. The pain and HRQL
instruments were selected based on our previous
work[43,44] and that of Walters et al. [10,45]. In the Wal-
ters study, the SF-36, EuroQol (EQ), SF-MPQ and the
Frenchay Activities Index (FAI) were evaluated with 233
individuals on three occasions over one year. The SF-MPQ
was more responsive than the other instruments and
detected changes at the 3-month and 12-month follow-
up. Based on these results it was recommended that SF-
MPQ be used to evaluate outcomes of interventions with
a short-term follow-up (three months), and that SF-36 be
used for 12-month follow-up with or without the SF-
MPQ. From the SF-36 a shorter 12-question version (SF-
12) has been developed and evaluated [41,46] with the
Physical and Mental Component Scores correlating very
highly with the SF-36 version (Medical Outcomes Trust
source pages). Thus we opted to use the shorter SF-12 to
reduce the burden of response as we have found in previ-
ous studies it took 5–8 minutes to complete compared to
11 minutes for the SF-36. Canadian normative data were
used for comparison purposes with the SF-12 [47].
Satisfaction with care was assessed through two surveys
administered at the 3-month point. This provided data on
individual's perceptions of the impact of the leg ulcer on
their personal lives and the satisfaction with the care they
received in either the clinic or home setting.
Basic resource use for an episode of ulcer care (referral to
healing) related to the both clinic and home setting were
assessed including; number and weekly frequency of vis-
its, all supplies and materials provided through the home
care authority. The Practice Audit Tool, used in our previ-
ous work, captures supplies (bandaging and dressing) and
nursing visits for the clinic or home care. Acquisition costs
of the different bandage systems and other supplies was
calculated from the retail prices quoted by the manufac-
turers. Expenditures differ depending on setting of care for
both the system and the patients and families. Given this
a comprehensive economic analysis would require a soci-
etal, rather than sector, perspective. In such an analyses, all
expenditures such as travel time to provide or receive care
(nurse and patient), vehicle allowances for nurses, over-
head of the community located leg ulcer clinic settings
(rent, utilities, reception, etc.), and family expenditures
related to leg ulcer care (time off work, travel, out-of-
pocket expenses etc.) would be required. It was beyond
the scope of this trial to assess all the indirect and direct
costs related to home and clinic care. Basic resource data
on an episode of care (admission to discharge) collected
in this trial may provide the basis in planning for a full
economic analysis or modeling study.
Sample size
From data collected in our initial prevalence study, 20%
of cases had healed within a 3-month period, comparable
to rates of ulcer healing reported in the literature. Thus
sample size was based on detecting a difference of 20% in
3-month healing rates in favour of the clinic setting. We
expected the absolute rate of healing in the clinic group at
3-months to be 40%, a figure falling between the extremes
(20%–89%) for 3-month healing rates in previously
reported leg ulcer clinic studies [11,13]. To detect a 20%
difference, with a power of 80% at a significance level of
.05 (two-tailed), 100 patients per group was required.
Analyses
The primary data analysis was based on 'intention to
treat'. The proportion of individuals in each group healed
at 3 months (91 days) and recurrence rates were com-
pared using Chi squared tests. Mean number of visits for
the ulcer episode (admission to discharge), weeks on serv-
ice, visits per week were calculated for the home and the
clinic groups. Mean differences in health status outcomes
(SF-12, pain) and resource variables were compared
between the treatment arms of the trial using the inde-
pendent t-test of either the pooled or separate variance
estimates as appropriate. Variables with a non-normal dis-
tribution were analyzed with the appropriate non-para-
metric procedures, Mann-Whitney for unpaired data and
Wilcoxon for paired data.BMC Health Services Research 2008, 8:243 http://www.biomedcentral.com/1472-6963/8/243
Page 5 of 10
(page number not for citation purposes)
Results
Over a 37 month recruitment period (November 7 2000
– March 17 2003), 759 individuals referred for home care
were screened (see Figure 1). Of these 44% (n = 334) were
assessed as mobile and able to travel outside their homes,
and therefore eligible to receive clinic care. After assess-
ment, 69% (n = 230) presented with venous disease or
mixed venous and arterial etiology and were eligible for
compression bandages. When approached, 45% (n = 104)
indicated that they were willing to be studied in terms of
healing but declared a strong preference for receiving care
in either the home or a clinic setting. Therefore, this group
was followed but not randomized. The remaining 126
people were willing to be randomized and these individ-
uals were entered in the trial. There were no significant
differences on profile characteristics between the 'stated
preference' group and the trial group.
Of the 126 trial participants, 65 were randomized to
receive care in their homes, and 61 to the nurse-run clinic.
There were no differences on admission between the par-
ticipants randomized to either the clinic and home care
groups on their socio-demographic, circumstance of liv-
ing, health-related quality of life or clinical characteristics
(Table 1). Mean age of the trial group was 69 years. There
were more women (68%) than men and the majority was
English-speaking (84%). Half had at least one previous
episode of ulceration and 60% experienced a current ulcer
smaller than 5 cm2 for less than 6 months. Health related
quality of life was poor on the SF-12 physical component;
these individuals' baseline scores were much lower than
the Canadian norm (35.1 vs 51.7). The SF-12 mental
component score was similar to the Canadian norm (49.7
vs 50.5).[47] In tracking the evidence-based protocol,
there were no differences found in key aspects of the clin-
ical care received by the two groups (Table 2).
Healing
The healing rate was not significantly different between
groups. 58.3% of the group receiving clinic care healed at
3 months compared to 56.7% for those receiving home
care (p = 0.5). Similarly there was no significant difference
in durability of healing; recurrence rates within one year
were 24.6% in the clinic group compared to 21.5% (p =
0.42) in the home group (see Table 3). Mean time free of
ulcers after healing was 190 days (sd 91.5 days) for the
home group and 159 days (sd 87.3 days) for those receiv-
ing care in the clinic. Five cases were missing in the home
group and one in the clinic group on the primary outcome
due to refusal, unable to track or deaths.
Pain and health-related quality of life
At 3 months, the majority of the clinic group (63%)
reported 'no pain' compared to 52% of the home care
group with no statistically significant differences between
the groups on their pain assessments. Health related qual-
ity of life scores physical (PCS) and mental component
scores (MCS) were not statistically different between the
groups. In comparison to baseline, the clinic group
improved more on the MCS (from 48.4 to 53.9) than the
home care group (50.9 to 51.8).
Individual's satisfaction with care
Overall the majority of individuals were very satisfied
(95%) with the care received in the past 12 months and
93% would recommend it to others (Table 4). Individuals
receiving clinic care reported less waiting time for nurse
with 80% of the home having 30 minutes or less com-
pared to 98% of clinic group (p = 0.03). Both home and
clinic groups reported high satisfaction levels with the
information they receive on how to care for their leg ulcers
(98% vs. 96% very/quite satisfied, respectively). Similar
proportions in both the home and clinic groups reported
Flow of population with leg ulcers and eligible pool for clinic vs home trial Figure 1
Flow of population with leg ulcers and eligible pool for clinic vs home trial.
Eligible for 
Randomization  
MOBILE 
NO 
n = 425 
YES YES 
n = 126 
CLINIC CARE 
n = 61 
HOME CARE 
n = 65 
NO
Preference 
stated prior to 
randomization
R 
N=230
n = 334
Population with 
leg ulcers 
referred for 
home care 
(n=759) 
n = 104 BMC Health Services Research 2008, 8:243 http://www.biomedcentral.com/1472-6963/8/243
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continued difficulties with normal activities (47% and
56% respectively) with the majority not feeling anxious or
depressed (72% and 73%).
Resource use
There were no differences statistically in the groups on
total number of nursing visits or visits per week, weeks on
service, or supplies (Table 5). On average 37 visits were
incurred for the episode of leg ulcer care (until healed)
with the average weeks on service being 18.7 for home
care and 17.3 for clinic care. It was not feasible to track the
actual time of visits used in the clinic and in home.
Although the number episodes of care were similar, this
does not account for additional travel time incurred by
nurses delivering home care. Due to constraints in how
much data individual nurse could collect we do not have
accurate information on the travel times for the home
delivery arm. This initial data will allow for economic
modeling in a further study.
Discussion
In this community trial, people with leg ulcers who were
mobile were randomized to receive care in either their
homes or in a nurse-led clinic. Care was delivered by the
same specially trained team of nurses in both settings
guided by an evidence-based protocol for assessment and
management. Healing at 3-months and recurrence were
comparable and not statistically different between the
Table 1: Comparison of the baseline characteristics of the study population and those allocated to clinic care and home care groups
TOTAL
(n = 126)
Home Group
(n = 65)
Clinic Group
(n = 61)
p-value
n(%) n (%) n (%)
Etiology of leg Ulcer
• Venous 86 (68.3) 45 (69.2) 41 (67.2) 0.85
• Mixed 40 (31.7) 20 (30.8) 20 (32.8)
Gender-Female 71 (56.3) 35 (53.8) 36 (59.0) 0.59
Language-English 106 (84.1) 56 (86.2) 50 (82.0) 0.79
Living Alone 54 (42.9) 29 (44.6) 25 (41.0) 0.72
Independently Mobile 89 (70.6) 45 (70.3) 44 (72.1) 0.84
Previous Ulceration 62 (49.2) 34 (52.3) 28 (45.9) 0.48
Prognostic Indicators
• Duration < 6 months, Ulcer size < 5 cm2 76 (60.3) 39(60.0) 37 (60.7) 0.13
• Duration > 6 months, Ulcer size < 5 cm2 13 (10.3) 5 (7.7) 8 (13.3)
• Duration < 6 months, Ulcer size > 5 cm2 23 (18.3) 10 (15.4) 13 (21.7)
• Duration > 6 months, Ulcer size > 5 cm2 14 (11.1) 11 (16.9) 3 (5.0)
Ulcer Size (cm 2) (median, range) 2.25
(.01–116.6)
2.4
(.04 – 116.6)
2.3
(.01–84.0)
Continuous variables Mean (SD) Mean (SD) Mean (SD
Mean Age (years) 68.5 (14.1) 68.3 (15.3) 68.7 (12.9) 0.86
SF12 Scores (n = 58)1 (n = 52)1
• Mental Component 49.7 (11.0) 50.9 (10.8) 48.4 (11.2) 0.75
• Physical component 35.1 (9.9) 35.5(10.3) 34.7 (9.7) 0.43
Diathesis in years 14.2 (15.9)
Median 8.0
11.0 (13.8)
Median 7.0
18.2 (17.7)
Median 10.0
0.05
Duration at initial assessment in weeks 30.4 (65.0) 24.98 (43.65) 36.26 (81.87) 0.96
1 12.7% of the clients were unable because of language barrier or unwilling to complete the Quality of Life questionnaires
Table 2: Description of the evidence-based protocol delivered in the clinic care and home care groups
Variables Home Group
(n = 65)
Clinic Group
(n = 61)
p-value
% (n) % (n)
Comprehensive Clinical Assessment 100 (65) 100 (61)
Doppler ABPI 96.9 (63) 96.7 (59) .970
Compression Therapy
All* 95.4 (62) 93.3 (56) .709
• Venous disease* 53.7 (44) 46.3 (38) .599
• Mixed Disease* 50.0 (18) 50.0 (18) 1.0
*Fisher's Exact Sig. (2-sided)BMC Health Services Research 2008, 8:243 http://www.biomedcentral.com/1472-6963/8/243
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clinic (58.3% healed, 24.6% recurred) and home care
group (56.7%, 21.5% recurred). Both groups had rela-
tively high healing rates at 3 months compared to what
has been reported in the literature which is likely due to
the organization and consistency in delivery of evidence-
based care in both settings.
In our first study[20] using a pre-post design, we demon-
strated the feasibility and acceptance of using an evidence-
based protocol. Results indicated that the implementa-
tion of evidence-based care with a specially trained team
was related to a more than doubling of healing at 3-
months and savings in terms of nursing time and supplies.
Further, this randomized health services trial provides the
first comprehensive evaluation of clinic versus home care
in a Canadian context. Unlike the UK studies, we found
similar outcomes in healing regardless of venue of care
provided that the quality of care is similar. This is due to
the organization of care in home and clinic being similar
in the current study whereas, the home delivered care was
more varied in the previous trials. We conclude that
organization of care is more important than setting with
the key elements being: an explicit evidence-based proto-
col, specially trained nurses with enough wound practice
to maintain skills, accessible equipment (e.g. dopplers,
high compression bandages), and administrative support
for a longer first visits to complete a comprehensive initial
assessment and development of a care plan. Given this,
Table 3: Healing, quality of life, and pain outcomes for those receiving an evidence-based protocol for leg ulcer care in either a nurse 
clinic or home care setting
Outcome Home Group Clinic Group p-value
Healing (n = 60)1
% (n)
(n = 60)2
% (n)
• 3-month (91 days) 56.7 (34) 58.3 (35) 0.50
Recurrence rate in one year 21.5 (14) 24.6 (15) 0.422
Pain (n = 52)3 (n = 49)4
• No pain 51.9 (27) 63.3 (31) 0.496
• Mild/Discomfort 36.5 (19) 26.5 (13)
• Distressing/horrible/excruciating 11.5 (6) 10.2 (5)
SF12 Scores (n = 52)3
n (sd)
(n = 46)5
n (sd)
• Mental Component 51.8 (11.8) 53.9 (9.1) 0.33
• Physical Component 39.2 (11.9) 38.9 (10.7) 0.89
1missing 5 cases
2missing 1 cases
3missing 9 cases
4missing 13 cases
5missing 15 cases
Note on missing cases: at the 3-month point cases are missing on the survey data (SF-12 and pain) due to individuals not being willing to complete 
forms. They agreed to have their clinical data collected but were not willing to complete any forms.
Table 4: Comparison at 3 month of the individuals perception of personal issues related to leg ulcer and satisfaction with care between 
those allocated to clinic care and home care groups
Home Group
(n = 54)
Clinic Group
(n = 48)
p value
% (n) n (%)
ISSUES (n = 102)
Some problems walking about 59.3 (32) 45.8 (22) 0.23
Some problems with washing, dressing self 18.5 (10) 12.5 (6) 0.43
Some problems performing my usual activities 42.6 (23) 56.3 (27) 0.28
Not anxious or depressed 72.2 (39) 72.9 (35) 0.59
SATISFACTION (n = 97) (n = 51) (n = 46)
• Waiting less than 30 minute 80.4 (41) 97.8 (45) 0.03
• Waiting 30 minutes – 1 hour 15.7 (8) 2.2 (1)
• Waiting 1–2 hours 3.9 (2) 0 (0)
Very/quite Satisfied with information 98.0 (50) 95.6 (44) 0.25
Very/quite Satisfied with treatment last 12 weeks 94.0 (47) 93.2 (41) 0.70
Very/quite Satisfied with nurses' skill 94.1 (48) 95.5 (43) 0.49
Recommend/highly recommend care you receive to others 93.9 (46) 90.9 (40) 0.58BMC Health Services Research 2008, 8:243 http://www.biomedcentral.com/1472-6963/8/243
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health service planners and decision-makers could offer
community leg ulcer care in either a clinic or home setting
and expect good results if the team follows an evidence
protocol and are specially trained. Such an option is
important in the Canadian environment because factors
such as, the size of the population, urban-rural mix, as
well as feasibility to set-up clinics in a region is quite var-
iable. Practically speaking, clinic care has the advantage of
readily available supplies that may hasten immediate
implementation of care once the comprehensive assess-
ment is complete compared to the home setting where
supplies may have to be ordered and delivered, resulting
in a delay in implementation of the treatment plan. With
nursing hours typically considered a scarce resource and
with increasing pressure on home care resources to take
on more, authorities might consider offering able clients
the option to attend clinics to access care.
An interesting phenomenon discovered during this trial
was that, although there was enthusiasm to participate in
a wound study with one-year follow-up commitment,
many participants expressed strong preferences with 54%
of these preferring home delivered care and 46% prefer-
ring clinic delivered care. In total, 40% of potential trial
participants were excluded from randomization due to
stated preference. A future study will examine if after
adjustment for co-morbid conditions, and severity and
duration of ulcer, whether populations with stated treat-
ment preferences have better outcomes regardless of treat-
ment selected.
Limitations of the study
Our trial has some limitations. First, it might be consid-
ered a limitation that nurses providing care were involved
in the collection of data. Blinding the nurse to the setting
was obviously not feasible and once bandages were
applied it would have been excessively intrusive (and
monumentally expensive) to remove them solely for the
purpose of an outcome assessment. On the other hand,
our small team of dedicated specially trained nurses,
ensured expert, quality outcome assessments by measur-
ing healing in a rigorous and consistent manner regardless
of setting.
Secondly, due to an unexpected expression of strong pref-
erence for either clinic or home-delivered care the trial
resulted in being underpowered, however given the
observed difference in rate of healing between the two
arms (1.6%). Assuming this difference is clinically signif-
icant (which most would agree it is not), the trial would
have required a sample size of approximately 15,000 per
arm to detect this difference. Even if the current trial con-
tinued until the predicted sample size was achieved (100
per arm) and the remaining ~40 patients per arm that
were recruited during this period, demonstrated a 20%
rate of healing in the clinic and a 40% rate of healing in
the home, the final healing rates of ~52% for clinic and
~45% for home, would not be statistically significant. The
1.6% difference obtained in our study is nowhere near the
20% difference anticipated based on previous studies.
Further, if this difference was considered clinically impor-
tant, which arguably it is not, we would have needed
~800/arm to demonstrate it. So although sample size was
not achieved, we were able to demonstrate that there were
no significant differences in healing rates between the two
groups and it will hopefully provide data for others to use
in developing sample sizes for future wound studies.
Thirdly, patient preference may have an impact on the
type of health services provided in a geographical area. It
will be important for future studies to systematically mon-
itor the reasons for an individual's stated preference to be
treated in either the home or at a clinic. In general, com-
ments indicated that many patients preferred clinic
because it gave them a specific appointment time versus
not knowing when the nurse was going to arrive at their
home, particularly for employed patients. For some, the
clinic provided an outing with social contact that would
otherwise not be available to them, while others felt it too
difficult to make the arrangements required to visit the
clinic, including transportation, parking and distance to
walk. However, many of the factors that lead to a stated
preference (e.g., mobility, employment, social contact)
also introduce bias into the sample, therefore future stud-
ies are necessary to examine the impact of preference on
outcome. Finally, our study took place in two regions
within southeastern Ontario that included both urban
Table 5: Resource utilization and costs by study group
Variables Home (n = 65) Clinic (n = 61) Statistics
Mean (sd) Mean (sd) p value
Nursing Visits for episode of Leg Ulcer Care 37.61 (31.596) 37.18 (44.328) .950
Weeks on Service 18.66 (14.453) 17.30 (14.659) .602
Visits per Week 2.12 (1.158) 2.12 (1.125) .950
Nursing Cost for Episode of Care of Leg Ulcer Client $1,868.01 ($1,615.24) $1,807.79 ($2,163.87) .859
Cost of Wound Supplies for Episode of Care $1,137.39 ($1,516.93) $905.14 ($1,714.91) .423BMC Health Services Research 2008, 8:243 http://www.biomedcentral.com/1472-6963/8/243
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and rural components, and a culturally mixed population.
These populations may not be representative of other
areas where high density or more homogenous popula-
tions are found.
Conclusion
The results from this health services trial differ from previ-
ous reports which have concluded that clinic care is supe-
rior to home care at improving leg ulcer healing.
Organization of care, rather than setting is the crucial fac-
tor. We found that when quality wound care was sup-
ported with a service model, i.e. following evidence-based
recommendations, and being delivered by a well-trained,
dedicated nursing team, that similar healing results can be
attained whether the leg ulcer care is delivered in the
home or in a nurse clinic. Our data also suggests that a sig-
nificant proportion of patients have preferences for care in
both settings. The trial provides the first Canadian data on
this health services issue and from a planning perspective,
if feasible in a region, health authorities should consider
both settings in order to provide mobile individuals with
choice. Future research will be needed to investigate the
relative efficiencies of clinic care compared to usual home
care with particular attention to local environment, the
various economies of scale (large, medium and small
health regions), population dispersion between urban
and rural, numbers of nursing agencies and nurse provid-
ers contracted to deliver wound care, organization of pri-
mary care and referral patterns and other important
contextual factors.
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